Massive Bio
Healthcare Software · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
90 West St, New York City, New York, 100...Phone Number
(844) 627-7246Website
www.massivebio.comRevenue
$21 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
3
5
2
2
About Massive Bio
Massive Bio's (https://massivebio.com) mission is to provide access to clinical trials for every cancer patient regardless of his/her location and/or financial stability. Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials, yielding profound improvement in access and match rates, leading to faster drug development timelines, and creating a novel oncology data ecosystem for improved protocol design and real-world insights. Massive Bio controls the patient enrollment value chain starting with patient identification, following with AI-based virtual pre-screening outside the site, and resolving last mile issues for clinical trial enrollment. While improving cancer patients lives, Massive Bio serves over two dozen pharmaceutical companies, contract research organizations (CROs) and hospital networks. In addition, Massive Bio has been awarded an SBIR contract by the National Cancer Institute (NCI) to develop and characteRead more
Massive Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Massive Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Massive Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Massive Bio
Product Launch: Get notified when Massive Bio launches new products
Click to see if Massive Bio had a recent Job posting/layoffs
Earning: See what the market has to say on Massive Bio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Massive Bio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Massive Bio has new funding data
Check out if Massive Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Massive Bio
Find 2 more new buyers
Compare Similar Companies to Massive Bio
Compare insights from companies similar to Massive Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Massive Bio is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Massive Bio is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Massive Bio.
Massive Bio financials insights
Gather financial insights about Massive Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$2.6M
2021
Debt
$74K
2022
Other Financing Round
$9M
Massive Bio Tech Stack
A closer look at the technologies used by Massive Bio
See more technologies
Most Recent Scoops
Open Position
Person-Based
Clinical Operations, Healthcare Technology
Partnership
Partnership, Customer Engagement, Business Development, Accessibility, Artificial Intelligence, Patient Experience
Person-Based
Partnership, Medical Research, Clinical Operations
Person-Based
Massive Bio News & Media
Massive Bio Partners with TOUCH BBCA and Navigating Trials to Expand Cancer Patients' Access to Clinical Trials
AI-powered trial matching now available through two trusted cancer advocacy and navigation platforms BOCA RATON, FL, UNITED STATES, May 29, 2026 /EINPresswire.com/ -- Massive Bio, a global precision oncology company, today announced a new partnership …Massive Bio to Unveil Reticulum Nexus™ as the AI Operating System for Oncology Access at ASCO 2026
Bridging cancer innovation and patient access through a trusted multi-agent platform. BOCA RATON, FL, UNITED STATES, May 28, 2026 /EINPresswire.com/ -- Massive Bio, a global leader in AI-enabled oncology trial access and precision oncology navigation, …Massive Bio and Just Worldwide to expand cancer trial access
Just Worldwide will utilise its engagement infrastructure to increase awareness of Massive Bio's clinical trials.Massive Bio Publishes Prospective Study on AI-Driven Clinical Trial Matching in 3,804 Cancer Patients
Neuro-symbolic AI achieves 4x faster trial matching with 17,000+ oncologist-confirmed matches, published in ESMO Real World Data and Digital Oncology. BOCA RATON, FL, UNITED STATES, April 9, 2026 /EINPresswire.com/ -- Massive Bio Publishes Peer-Reviewed …
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Massive Bio
Sign Up For FreeTo access detailed company insights
Massive Bio's (https://massivebio.com) mission is to provide access to clinical trials for every cancer patient regardless of his/her location and/or financial stability. Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials, yielding profound improvement in access and match rate... Read More
